Skip to content

PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS

PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03758066
Enrollment
65
Registered
2018-11-29
Start date
2019-01-02
Completion date
2020-12-31
Last updated
2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

youth, young adults, digital health, mobile application, case management

Brief summary

While major advancements in medical technology over the past decade have significantly improved the life expectancy of persons infected with human immunodeficiency virus (HIV), HIV-positive youth today face new barriers to the treatment of HIV as a chronic, manageable illness. The mobile system proposed will help improve linkage to care through mobile technology support for the case management of youth living with HIV. Results of this project will determine the impact of this system on case management processes and outcomes and have implications for the care of youth living with other chronic, complex illnesses.

Detailed description

With the advancement of medical treatments, which has contributed to the overall decrease in opportunistic infections and deaths related to human immunodeficiency virus (HIV) in youth, there is a need to ensure that youth living with HIV (YLH) are linked to and engaged in care to successfully achieve viral suppression. While an increasing number of mobile health (mHealth) technologies have been designed to address HIV prevention and care, a critical gap in innovation remains in tools designed to address the specific needs of YLH. In a Phase I project, investigators demonstrated the acceptability and feasibility of a user-centered prototype design of PlusCare, an mHealth application that can be used by YLH and their case managers (CMs) to support HIV care. Results of Phase I suggest that PlusCare could facilitate multi-disciplinary, team-based case management of YLH by supporting the sharing and signing of documents remotely, automation of adherence reminders, sharing of lab results, alerts CMs about program requirements related to age and developmental milestones, streamlining of communication between multiple members of a patient's case management team and the patient, and offering accessibility to data from multiple modalities. In this Phase II project, investigators will conduct a mixed methods, non-randomized pre-post study with CMs (N=20) and YLH patients (N=70) to examine the use of PlusCare on case management processes and health outcomes (i.e., HIV viral load, medical visit frequency and gaps) in 3 different case management programs at 2 different clinical study site settings. An initial cost analysis will be performed to assess potential cost effectiveness. Results of these Phase I and II projects will inform the development of a product that can be used in multiple case management settings and prepare PlusCare for future commercialization. Results have implications for future development of PlusCare to serve the broader HIV population (YLH aged 25-34 years old and at-risk individuals) as well as youth living with other chronic health conditions.

Interventions

DEVICEPlusCare

PlusCare is a mobile application designed to be used by youth and young adults with HIV and case managers.

Sponsors

Boston Children's Hospital
CollaboratorOTHER
Boston Medical Center
CollaboratorOTHER
Dimagi Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Pre-post quasi-experimental design

Eligibility

Sex/Gender
ALL
Age
13 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

PATIENTS: Inclusion Criteria: * between 13-25 years old * HIV positive * enrolled in treatment at a participating study site * owns or has ability to access a smartphone (e.g., iPhone, Android) for one year

Exclusion criteria

* Non-English speaker or * Visually/hearing impaired CASE MANAGERS: Inclusion Criteria: * Actively employed at a participating study site * Performs case management duties with HIV-positive patients aged 13-25 years.

Design outcomes

Primary

MeasureTime frameDescription
CD4 Cell Count1 year prior to baseline (pre), 1 year post-baseline (post)Comparison of average CD4 cell count (cells/mm\^3) between pre and post time points
Viral Load1 year prior to baseline (pre), 1 year post-baseline (post)Comparison of average viral load (copies/mL) between pre and post time points
Appointment Adherence Rate1 year prior to baseline (pre), 1 year post-baseline (post)Comparison of median appointment adherence ratio between pre and post time points, i.e., (Actual completed appointments) / (Expected appointments) where expected appointments includes completed appointments, no shows, and cancellations

Secondary

MeasureTime frameDescription
Proximal Outcomes (Monthly Medication Adherence Item)MonthlySelf-reported levels of medication adherence were reported on a monthly basis, where AYA living with HIV rated their adherence to their prescribed medication using the self-rating scale item (SRSI) single-item adherence measure. Patients reported medication adherence for the past month on a 6-point Likert scale ranging from 1 (very poor) to 6 (excellent). Patients received monthly SMS text messages alerting them to report adherence via survey forms created in the PlusCare app. Mean self-reported monthly medication adherence ratings across 12 months is reported.
System Usability (User Satisfaction): System Usability Scale1 yearSelf-reported ratings of perceived system usability on the 10-point Likert-scaled System Usability Scale (SUS) scored in a range of 0 of 100, with higher scores indicating higher usability, were collected at end of study.
Patient-centered Outcomes (Quality of Life): Self-reported Responses to Survey1 year (Baseline, 6-month, 12-month)Self-reported scores to the General Health item of the CDC Health Days Measure Core Module (CDC HRQOL-4) item were compared between 3 timepoints, with scores ranging from 1 (Poor) to 5 (Excellent).
Patient-centered Outcomes (Self-efficacy): Self-reported Responses to Survey1 year (Baseline, 6-month, 12-month)Self-reported average scores to the Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD6) were compared between 3 timepoints. SEMCD6 scores range from 1 to 10, with higher numbers indicating higher self-efficacy.

Countries

United States

Participant flow

Recruitment details

Study participants were recruited and enrolled into the study between January 2019 to June 2019 from 3 HIV/AIDS programs at two large, private, not-for-profit academic hospitals in the metro Boston area. Participants were case management program team members (CMs) and adolescents and young adults (AYA) living with HIV. CMs were enrolled and trained on the system first. Patients were then enrolled on a rolling basis. An RA at each site assessed eligibility, consented and enrolled participants.

Pre-assignment details

There were no significant effects that occurred after participant enrollment that affected enrolled participants receiving the intervention. This was a one-armed prospective study where participants were enrolled into the study and then enrolled into the PlusCare system in-person in one session.

Participants by arm

ArmCount
PlusCare
Patients and case managers who work with them will be given access to a web-/mobile-based application, PlusCare, to support various case management activities for one year. PlusCare: PlusCare is a mobile application designed to be used by youth and young adults with HIV and case managers.
65
Total65

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up14

Baseline characteristics

CharacteristicPlusCare
Age, Categorical
AYA living with HIV
<=18 years
12 Participants
Age, Categorical
AYA living with HIV
>=65 years
0 Participants
Age, Categorical
AYA living with HIV
Between 18 and 65 years
33 Participants
Age, Categorical
CM
<=18 years
0 Participants
Age, Categorical
CM
>=65 years
0 Participants
Age, Categorical
CM
Between 18 and 65 years
20 Participants
Education
AYA living with HIV
Bachelor's Degree
0 Participants
Education
AYA living with HIV
Doctoral Degree
0 Participants
Education
AYA living with HIV
High school graduate or less
24 Participants
Education
AYA living with HIV
Master's Degree
0 Participants
Education
AYA living with HIV
Professional Degree
0 Participants
Education
AYA living with HIV
Some college credit or more
20 Participants
Education
CM
Bachelor's Degree
7 Participants
Education
CM
Doctoral Degree
4 Participants
Education
CM
High school graduate or less
0 Participants
Education
CM
Master's Degree
7 Participants
Education
CM
Professional Degree
2 Participants
Education
CM
Some college credit or more
0 Participants
Hours on the phone per day
AYA living with HIV
0-3 hours
8 Participants
Hours on the phone per day
AYA living with HIV
4-6 hours
19 Participants
Hours on the phone per day
AYA living with HIV
7+ hours
18 Participants
Hours on the phone per day
CM
0-3 hours
9 Participants
Hours on the phone per day
CM
4-6 hours
8 Participants
Hours on the phone per day
CM
7+ hours
3 Participants
Race/Ethnicity, Customized
AYA living with HIV
Hispanic/Latino
8 Participants
Race/Ethnicity, Customized
AYA living with HIV
Not Hispanic, Black
24 Participants
Race/Ethnicity, Customized
AYA living with HIV
Not Hispanic, Other (incl. Native American, Asian/Pacific Islander, More than one)
6 Participants
Race/Ethnicity, Customized
AYA living with HIV
Not Hispanic, White
4 Participants
Race/Ethnicity, Customized
AYA living with HIV
Unknown ethnicity
3 Participants
Race/Ethnicity, Customized
CM
Hispanic/Latino
1 Participants
Race/Ethnicity, Customized
CM
Not Hispanic, Black
4 Participants
Race/Ethnicity, Customized
CM
Not Hispanic, Other (incl. Native American, Asian/Pacific Islander, More than one)
1 Participants
Race/Ethnicity, Customized
CM
Not Hispanic, White
12 Participants
Race/Ethnicity, Customized
CM
Unknown ethnicity
2 Participants
Sex: Female, Male
AYA living with HIV
Female
23 Participants
Sex: Female, Male
AYA living with HIV
Male
22 Participants
Sex: Female, Male
CM
Female
18 Participants
Sex: Female, Male
CM
Male
2 Participants
Smartphone ownership
AYA living with HIV
Android
5 Participants
Smartphone ownership
AYA living with HIV
iPhone
40 Participants
Smartphone ownership
CM
Android
3 Participants
Smartphone ownership
CM
iPhone
17 Participants
Tech savvy
AYA living with HIV
7.86 units on a scale
STANDARD_DEVIATION 1.58
Tech savvy
CM
7.05 units on a scale
STANDARD_DEVIATION 1.23

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 65
other
Total, other adverse events
0 / 65
serious
Total, serious adverse events
0 / 65

Outcome results

Primary

Appointment Adherence Rate

Comparison of median appointment adherence ratio between pre and post time points, i.e., (Actual completed appointments) / (Expected appointments) where expected appointments includes completed appointments, no shows, and cancellations

Time frame: 1 year prior to baseline (pre), 1 year post-baseline (post)

ArmMeasureGroupValue (MEDIAN)Dispersion
PlusCareAppointment Adherence RatePre0.60 appointment adherence ratioStandard Deviation 0.19
PlusCareAppointment Adherence RatePost.67 appointment adherence ratioStandard Deviation 0.25
Primary

CD4 Cell Count

Comparison of average CD4 cell count (cells/mm\^3) between pre and post time points

Time frame: 1 year prior to baseline (pre), 1 year post-baseline (post)

ArmMeasureGroupValue (MEAN)
PlusCareCD4 Cell CountPre996 cells/mm^3
PlusCareCD4 Cell CountPost1049 cells/mm^3
Primary

Viral Load

Comparison of average viral load (copies/mL) between pre and post time points

Time frame: 1 year prior to baseline (pre), 1 year post-baseline (post)

ArmMeasureGroupValue (MEAN)
PlusCareViral LoadPre32.0 copies/mL
PlusCareViral LoadPost24.7 copies/mL
Secondary

Patient-centered Outcomes (Quality of Life): Self-reported Responses to Survey

Self-reported scores to the General Health item of the CDC Health Days Measure Core Module (CDC HRQOL-4) item were compared between 3 timepoints, with scores ranging from 1 (Poor) to 5 (Excellent).

Time frame: 1 year (Baseline, 6-month, 12-month)

Population: Participants who completed the quality of life general health assessment (CDC HRQOL-4) at baseline, 6 months, and 12 months (end of study).

ArmMeasureGroupValue (MEAN)Dispersion
PlusCarePatient-centered Outcomes (Quality of Life): Self-reported Responses to SurveyBaseline3.6 score on a scaleStandard Deviation 0.12
PlusCarePatient-centered Outcomes (Quality of Life): Self-reported Responses to Survey6-month3.6 score on a scaleStandard Deviation 0.16
PlusCarePatient-centered Outcomes (Quality of Life): Self-reported Responses to Survey12-month3.9 score on a scaleStandard Deviation 0.16
Comparison: A two-tailed non-parametric one-sample paired sign test was used to determine whether to reject or fail to reject the null hypothesis that the mean difference of scores between any of the 2 of 3 timepoints is 0 (Baseline v. 6-month, 6-month v. 12-month, and Baseline v. 12-month).p-value: 0.03Sign test
Secondary

Patient-centered Outcomes (Self-efficacy): Self-reported Responses to Survey

Self-reported average scores to the Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD6) were compared between 3 timepoints. SEMCD6 scores range from 1 to 10, with higher numbers indicating higher self-efficacy.

Time frame: 1 year (Baseline, 6-month, 12-month)

Population: Participants who completed self-efficacy assessment (SEMCD6) at baseline, 6 months, and 12 months (end of study).

ArmMeasureGroupValue (MEAN)Dispersion
PlusCarePatient-centered Outcomes (Self-efficacy): Self-reported Responses to SurveyBaseline7.8 score on a scaleStandard Deviation 0.3
PlusCarePatient-centered Outcomes (Self-efficacy): Self-reported Responses to Survey6-month7.8 score on a scaleStandard Deviation 0.36
PlusCarePatient-centered Outcomes (Self-efficacy): Self-reported Responses to Survey12-month8.6 score on a scaleStandard Deviation 0.27
Comparison: A two-tailed non-parametric one-sample paired sign test was used to determine whether to reject or fail to reject the null hypothesis that the mean difference of scores between any of the 2 of 3 timepoints is 0 (Baseline v. 6-month, 6-month v. 12-month, and Baseline v. 12-month).p-value: 0.02Sign test
p-value: 0.02Sign test
Secondary

Proximal Outcomes (Monthly Medication Adherence Item)

Self-reported levels of medication adherence were reported on a monthly basis, where AYA living with HIV rated their adherence to their prescribed medication using the self-rating scale item (SRSI) single-item adherence measure. Patients reported medication adherence for the past month on a 6-point Likert scale ranging from 1 (very poor) to 6 (excellent). Patients received monthly SMS text messages alerting them to report adherence via survey forms created in the PlusCare app. Mean self-reported monthly medication adherence ratings across 12 months is reported.

Time frame: Monthly

ArmMeasureValue (MEAN)Dispersion
PlusCareProximal Outcomes (Monthly Medication Adherence Item)4.7 score on a scaleStandard Deviation 0.23
Secondary

System Usability (User Satisfaction): System Usability Scale

Self-reported ratings of perceived system usability on the 10-point Likert-scaled System Usability Scale (SUS) scored in a range of 0 of 100, with higher scores indicating higher usability, were collected at end of study.

Time frame: 1 year

Population: Summary of SUS scores reported for 13 (out of 20) CMs and 38 (out of 45) AYA living with HIV participants who completed the survey.

ArmMeasureGroupValue (MEAN)Dispersion
PlusCareSystem Usability (User Satisfaction): System Usability ScaleCM51 score on a scaleStandard Deviation 7.9
PlusCareSystem Usability (User Satisfaction): System Usability ScaleAYA living with HIV63 score on a scaleStandard Deviation 10.6

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026